Benjamin Edwards’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$346K Hold
2,197
– – ﹤0.01% 1203
2026
Q2
$348K Hold
2,197
– – ﹤0.01% 1172
2026
Q1
$281K Hold
2,197
– – ﹤0.01% 1187
2025
Q4
$268K Hold
2,197
– – ﹤0.01% 1158
2025
Q3
$220K Buy
+2,197
New +$198K ﹤0.01% 1216
2025
Q1
– Sell
-2,475
Closed -$223K – 1173
2024
Q4
$223K Hold
2,475
– – ﹤0.01% 1054
2024
Q3
$245K Buy
+2,475
New +$243K ﹤0.01% 1011

Other funds holding XBI

Benjamin Edwards's XBI Position: Q3 2026 in Review

Benjamin Edwards held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 2,197 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Benjamin Edwards first reported a position in XBI in Q3 2024 and has held it in 7 quarters since. The position peaked at $348K in Q2 2026. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Benjamin Edwards held 2,197 shares of State Street SPDR S&P Biotech ETF worth $346K as of Q3 2026.
  • Benjamin Edwards left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1203 holding.
  • Benjamin Edwards first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 7 quarters since.
  • Benjamin Edwards's State Street SPDR S&P Biotech ETF position peaked at $348K in Q2 2026.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.